Phase ll Trial of Fludarabine & Cyclophosphamide followed by Thalidomide for Angioimmunoblastic Lymphoma
- Registry ID
- EUCTR2005-003931-40
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- University College London
- Start date
- 2006-04-12
- Completion date
- 2014-01-08
- Last update
- 2026-08-16
Conditions
- Angioimmunoblastic T-cell lymphoma
Summary
To assess the response rate of patients treated with FluCy (Fludarabine and cyclophosphamide) chemptherapy.
Locations
View on source registry